Financial Architects (New Jersey)’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Financial Architects (New Jersey)’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10	Closed	-$7K	–	1476
2018 Q4	$7K	Buy	+10	New	+$10.5K	﹤0.01%	1071
2017 Q1	–	Sell	-351	Closed	-$220K	–	1599
2016 Q4	$220K	Hold	351	–	–	0.05%	235
2016 Q3	$343K	Sell	351 -129	-27%	-$106K	0.09%	174
2016 Q2	$271K	Buy	480 +200	+71%	+$125K	0.08%	187
2016 Q1	$154K	Buy	+280	New	+$177K	0.06%	225

Other funds holding LABU

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

HJMC

Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HIS

Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return

EWA

Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Financial Architects (New Jersey)'s LABU Position: Q1 2019 in Review

Financial Architects (New Jersey) sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2019, closing a stake of 10 shares — an estimated $7K sold.

Financial Architects (New Jersey) first reported a position in LABU in Q1 2016 and held it in 5 quarters. The position peaked at $343K in Q3 2016. 23 funds tracked by Wall St. Rank hold LABU as of Q1 2019.

Financial Architects (New Jersey) reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 10 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2019, an estimated $7K.
Financial Architects (New Jersey) first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2016 and held it in 5 quarters.
Financial Architects (New Jersey)'s Direxion Daily S&P Biotech Bull 3X ETF position peaked at $343K in Q3 2016.
23 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2019, filed 3 May 2019.